✦ LIBER ✦

Effectiveness of Fluvoxamine and Paroxetine in Major Depressives with Psychotic Features

✍ Scribed by EMILIO SACCHETTI; GIOVANNI CONTE; LAURA GUARNERI; ALESANDRO CALZERONI; MARA BERTINI; ADELAIDE PANARIELLO

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 62 KB
Volume: 12
Category: Article
ISSN: 0885-6222
DOI: 10.1002/(sici)1099-1077(199705/06)12:3<277::aid-hup858>3.0.co;2-e

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Effect of Paroxetine and Dothiepin o

The Effect of Paroxetine and Dothiepin on Subjective Sleep in Depressed Patients

✍ JOHN S. KERR; DIANE B. FAIRWEATHER; IAN HINDMARCH 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

Paroxetine improve the quality of sleep and the ease of waking up on subjective measures of sleep (the LSEQ). Dothiepin in contrast improved the ease of getting to sleep, but caused a reduced quality of sleep and a `hangover' eect the next morning.

The Val66Met polymorphism of the brain-d

The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients

✍ Jun-Ichi Iga; Shu-Ichi Ueno; Ken Yamauchi; Shusuke Numata; Sumiko Tayoshi-Shibuy 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 2 views

Neuroendocrine and anthropometric measur

Neuroendocrine and anthropometric measures in major depression: the effect of antidepressant treatment

✍ Arun Ravindran; Robert Bialik; Pavel Hrdina; Zul Merali; Hymie Anisman; Yvon Lap 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

It has been suggested that weight change might be associated with certain neuroendocrine abnormalities often observed in patients suering from a depressive illness. This preliminary study examined whether objective measures of weight change were associated with dexamethasone suppression test (DST) r

Physiological effects of electroconvulsi

Physiological effects of electroconvulsive therapy and transcranial magnetic stimulation in major depression

✍ Martin P. Szuba; John P. O'Reardon; Dwight L. Evans 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

Comparison of pramipexole, fluoxetine, a

Comparison of pramipexole, fluoxetine, and placebo in patients with major depression

✍ Mark H. Corrigan; Angelita Q. Denahan; C. Eugene Wright; Rhonda J. Ragual; Dwigh 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB 👁 2 views

Pramipexole, a dopamine D 2 receptor agonist, was tested in 174 patients with major depression, with or without melancholia and without psychotic features. Three daily dose levels (0.375 mg, 1.0 mg, and 5.0 mg) were compared to fluoxetine (Prozac) at 20 mg and placebo in a randomized, double-blind,

Effects of nortriptyline and paroxetine

Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder

✍ Vikram K. Yeragani; Robert Pohl; V.C. Jampala; Richard Balon; C. Ramesh; K. Srin 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 2 views

This study investigated beat-to-beat QT variability in patients with panic disorder before and after treatment with nortriptyline (n = 13) and paroxetine (n = 16), using an automated algorithm to compute QT intervals. An increase in QT variability appears to be associated with symptomatic patients w